• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

内源性阿片系统在抑郁症习得性无助模型中的作用

Implication of endogenous opioid system in the learned helplessness model of depression.

作者信息

Tejedor-Real P, Mico J A, Maldonado R, Roques B P, Gibert-Rahola J

机构信息

Department of Neurosciences, School of Medicine, Cádiz, Spain.

出版信息

Pharmacol Biochem Behav. 1995 Sep;52(1):145-52. doi: 10.1016/0091-3057(95)00067-7.

DOI:10.1016/0091-3057(95)00067-7
PMID:7501657
Abstract

The involvement of opioid system on the learned helplessness model of depression was investigated. Animals preexposed to inescapable shocks were treated with either Met-enkephalin, Leu-enkephalin, morphine, imipramine, naloxone, RB 38A (a mixed inhibitor of enkephalin degrading enzymes), or RB 38B (a selective inhibitor of neutral endopeptidase EC 3.4.24.11). Stimulation of opioid system by either opioid agonists or enkephalin catabolism inhibitors reversed the escape deficit induced by shock pretreatment. In contrast, administration of naloxone potentiated the effect of inescapable shocks. Imipramine reduced the number of escape failures in this test, and this effect was antagonized by naloxone. These results point to the involvement of the endogenous opioid system in this model of depression.

摘要

研究了阿片系统在抑郁症习得性无助模型中的作用。预先暴露于不可逃避电击的动物分别用甲硫氨酸脑啡肽、亮氨酸脑啡肽、吗啡、丙咪嗪、纳洛酮、RB 38A(脑啡肽降解酶的混合抑制剂)或RB 38B(中性内肽酶EC 3.4.24.11的选择性抑制剂)进行处理。阿片类激动剂或脑啡肽分解代谢抑制剂对阿片系统的刺激可逆转电击预处理诱导的逃避缺陷。相反,给予纳洛酮可增强不可逃避电击的作用。丙咪嗪减少了该试验中的逃避失败次数,且这种作用被纳洛酮拮抗。这些结果表明内源性阿片系统参与了该抑郁症模型。

相似文献

1
Implication of endogenous opioid system in the learned helplessness model of depression.内源性阿片系统在抑郁症习得性无助模型中的作用
Pharmacol Biochem Behav. 1995 Sep;52(1):145-52. doi: 10.1016/0091-3057(95)00067-7.
2
Effect of mixed (RB 38A) and selective (RB 38B) inhibitors of enkephalin degrading enzymes on a model of depression in the rat.
Biol Psychiatry. 1993;34(1-2):100-7. doi: 10.1016/0006-3223(93)90262-c.
3
Involvement of delta-opioid receptors in the effects induced by endogenous enkephalins on learned helplessness model.δ-阿片受体在内源性脑啡肽对习得性无助模型诱导的效应中的作用。
Eur J Pharmacol. 1998 Jul 31;354(1):1-7. doi: 10.1016/s0014-2999(98)00423-3.
4
Effects of morphine, naloxone and their interaction in the learned-helplessness paradigm in rats.
Psychopharmacology (Berl). 1996 Jan;123(1):71-8. doi: 10.1007/BF02246283.
5
Analgesic responses elicited by endogenous enkephalins (protected by mixed peptidase inhibitors) in a variety of morphine-sensitive noxious tests.内源性脑啡肽(受混合肽酶抑制剂保护)在多种对吗啡敏感的伤害性试验中引发的镇痛反应。
Eur J Pharmacol. 1991 Jan 10;192(2):253-62. doi: 10.1016/0014-2999(91)90050-z.
6
Differences in physical dependence induced by selective mu or delta opioid agonists and by endogenous enkephalins protected by peptidase inhibitors.
Brain Res. 1990 Jun 18;520(1-2):247-54. doi: 10.1016/0006-8993(90)91712-p.
7
Dopaminergic and opioidergic mediations of tricyclic antidepressants in the learned helplessness paradigm.
Pharmacol Biochem Behav. 1999 Nov;64(3):541-8. doi: 10.1016/s0091-3057(99)00102-1.
8
Reversal of learned helplessness by morphine in rats: involvement of a dopamine mediation.
Pharmacol Biochem Behav. 1998 Jun;60(2):519-25. doi: 10.1016/s0091-3057(98)00002-1.
9
Antinociceptive response induced by mixed inhibitors of enkephalin catabolism in peripheral inflammation.脑啡肽分解代谢混合抑制剂在外周炎症中诱导的抗伤害感受反应。
Pain. 1994 Jul;58(1):77-83. doi: 10.1016/0304-3959(94)90186-4.
10
Noradrenergic and opioid mediation of tricyclic-induced reversal of escape deficits caused by inescapable shock pretreatment in rats.去甲肾上腺素能和阿片类物质对三环类药物诱导逆转大鼠不可逃避电击预处理所致逃避缺陷的介导作用。
Psychopharmacology (Berl). 1986;90(1):90-4. doi: 10.1007/BF00172877.

引用本文的文献

1
Role of the mesolimbic dopamine pathway in the antidepressant effects of ketamine.中脑边缘多巴胺通路在氯胺酮抗抑郁作用中的作用。
Neuropharmacology. 2023 Mar 1;225:109374. doi: 10.1016/j.neuropharm.2022.109374. Epub 2022 Dec 11.
2
The mu opioid receptor and the orphan receptor GPR151 contribute to social reward in the habenula.孤啡肽 μ 型受体和孤儿受体 GPR151 共同作用于缰核中的社会奖励。
Sci Rep. 2022 Nov 24;12(1):20234. doi: 10.1038/s41598-022-24395-z.
3
The opioid system in depression.抑郁症中的阿片类系统。
Neurosci Biobehav Rev. 2022 Sep;140:104800. doi: 10.1016/j.neubiorev.2022.104800. Epub 2022 Jul 30.
4
Mechanisms Underlying the Anti-Suicidal Treatment Potential of Buprenorphine.丁丙诺啡抗自杀治疗潜力的潜在机制。
Adv Drug Alcohol Res. 2021;1. doi: 10.3389/adar.2021.10009. Epub 2021 Aug 3.
5
Mice Lacking GABA Receptor Subunit Have Altered Pharmaco-EEG Responses to Multiple Drugs.缺乏γ-氨基丁酸受体亚基的小鼠对多种药物的药物脑电图反应发生改变。
Front Pharmacol. 2021 Jun 21;12:706894. doi: 10.3389/fphar.2021.706894. eCollection 2021.
6
Reduced nucleus accumbens enkephalins underlie vulnerability to social defeat stress.伏隔核脑啡肽减少导致易患社交挫败应激。
Neuropsychopharmacology. 2019 Oct;44(11):1876-1885. doi: 10.1038/s41386-019-0422-8. Epub 2019 May 27.
7
m-Trifluoromethyl-diphenyl Diselenide Regulates Prefrontal Cortical MOR and KOR Protein Levels and Abolishes the Phenotype Induced by Repeated Forced Swim Stress in Mice.m-三氟甲基二苯二硒醚调节前额皮质 MOR 和 KOR 蛋白水平,并消除反复强迫游泳应激诱导的小鼠表型。
Mol Neurobiol. 2018 Dec;55(12):8991-9000. doi: 10.1007/s12035-018-1024-x. Epub 2018 Apr 5.
8
Major Depressive Disorder and Kappa Opioid Receptor Antagonists.重度抑郁症与κ阿片受体拮抗剂
Transl Perioper Pain Med. 2016;1(2):4-16.
9
The anxiolytic- and antidepressant-like effects of ATPM-ET, a novel κ agonist and μ partial agonist, in mice.新型κ激动剂和μ部分激动剂ATPM-ET对小鼠的抗焦虑和抗抑郁样作用。
Psychopharmacology (Berl). 2016 Jun;233(12):2411-8. doi: 10.1007/s00213-016-4292-z. Epub 2016 Apr 26.
10
Association Between Placebo-Activated Neural Systems and Antidepressant Responses: Neurochemistry of Placebo Effects in Major Depression.安慰剂激活的神经系统与抗抑郁反应之间的关联:重度抑郁症中安慰剂效应的神经化学机制
JAMA Psychiatry. 2015 Nov;72(11):1087-94. doi: 10.1001/jamapsychiatry.2015.1335.